Gilead Sciences
GILD
#113
Rank
C$225.75 B
Marketcap
C$181.89
Share price
-1.90%
Change (1 day)
26.92%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): C$9.50

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$9.35. In 2024 the company made an earnings per share (EPS) of C$0.52 a decrease over its 2023 EPS that were of C$6.21.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$9.501731.44%
2024C$0.52-91.65%
2023C$6.2123.98%
2022C$5.01-25.86%
2021C$6.754850%
2020C$0.14-97.64%
2019C$5.790.9%
2018C$5.7318.71%
2017C$4.83-64.88%
2016C$13.76-18.45%
2015C$16.8755.28%
2014C$10.86296.02%
2013C$2.7417.89%
2012C$2.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.20 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.86-80.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$3.26-65.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.42 236.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$19.55 109.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$12.05 28.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.48-20.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$21.11 125.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.98 6.72%๐Ÿ‡บ๐Ÿ‡ธ USA